Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats

1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2008-01, Vol.294 (1), p.E69-E77
Hauptverfasser: Koulmann, Nathalie, Bahi, Lahoucine, Ribera, Florence, Sanchez, Herve, Serrurier, Bernard, Chapot, Rachel, Peinnequin, Andre, Ventura-Clapier, Renee, Bigard, Xavier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E77
container_issue 1
container_start_page E69
container_title American journal of physiology: endocrinology and metabolism
container_volume 294
creator Koulmann, Nathalie
Bahi, Lahoucine
Ribera, Florence
Sanchez, Herve
Serrurier, Bernard
Chapot, Rachel
Peinnequin, Andre
Ventura-Clapier, Renee
Bigard, Xavier
description 1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype. muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )
doi_str_mv 10.1152/ajpendo.00173.2007
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_20865195</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70194482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</originalsourceid><addsrcrecordid>eNqFks1u1DAUhS0EokPhBVggiwUrZvBPnJ9lVbUUaSQ2w9pybKfxyLFTO6bkMXhjnE5aEEJiZcn3O9f3-B4A3mK0w5iRT-I4aqf8DiFc0R1BqHoGNrlAtpgx9hxsEG7oFtdFcwZexXhEmWAFeQnOcNVUmGG2AT8P_Ry8UbD3YfBOQxNh0HfJBK1g5wOceg3HXjs_zaOGUxAumsl4F6FxKslMtfMKiTAI6a2_NVLYXO5N-4BC38F8I43TKRiXK1CoZCcYvdUpwiFFafVCBTHF1-BFJ2zUb9bzHHy7vjpc3mz3Xz9_ubzYb2VRk2kryhqRriiLWraiZm2nqrrI5itVL-4kaQshqVSlaFuc3VIpNW0r0VWqlZQ09Bx8PPXtheVjMIMIM_fC8JuLPTcu6jBwhGjNWFN9xxn_cMLH4O-SjhMfTJTaWuG0T5FX-bOLPNl_QYLqkuGGZfD9X-DRp-CyZ04oobig5fIsOUEy-BiD7p5GxYgvKeBrCvhDCviSgix6t3ZO7aDVb8m69gzUq3dz29_nXfOxn6NZdjfz62TtQf-YHjuTpuCYX5UNH1X3x7f9Q_o4y5OE_gKT0dbR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232314361</pqid></control><display><type>article</type><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</creator><creatorcontrib>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</creatorcontrib><description>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype. muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00173.2007</identifier><identifier>PMID: 17971515</identifier><identifier>CODEN: AJPMD9</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Age Factors ; Animals ; Biochemistry, Molecular Biology ; Calcineurin ; Calcineurin - genetics ; Calcineurin - metabolism ; Calcineurin Inhibitors ; Catalytic Domain ; Cyclosporine ; Cyclosporine - blood ; Cyclosporine - pharmacology ; Electrophoresis, Polyacrylamide Gel ; Enzyme Inhibitors ; Enzyme Inhibitors - blood ; Enzyme Inhibitors - pharmacology ; Gene expression ; Genotype &amp; phenotype ; Growth hormones ; Hypothyroidism ; Hypothyroidism - metabolism ; Life Sciences ; Male ; Metabolism ; Muscle Proteins ; Muscle Proteins - genetics ; Muscle Proteins - metabolism ; Muscle, Skeletal ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - enzymology ; Myosin Heavy Chains ; Myosin Heavy Chains - metabolism ; p38 Mitogen-Activated Protein Kinases ; p38 Mitogen-Activated Protein Kinases - metabolism ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Phenotype ; Phosphorylation ; Proteins ; Rats ; Rats, Wistar ; RNA, Messenger ; RNA, Messenger - metabolism ; RNA-Binding Proteins ; RNA-Binding Proteins - genetics ; RNA-Binding Proteins - metabolism ; Rodents ; Thyroid Hormones ; Thyroid Hormones - metabolism ; Transcription Factors ; Transcription Factors - genetics ; Transcription Factors - metabolism</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2008-01, Vol.294 (1), p.E69-E77</ispartof><rights>Copyright American Physiological Society Jan 2008</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</citedby><cites>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</cites><orcidid>0000-0002-6116-5795 ; 0000-0002-7488-4123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3026,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17971515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-00385597$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Koulmann, Nathalie</creatorcontrib><creatorcontrib>Bahi, Lahoucine</creatorcontrib><creatorcontrib>Ribera, Florence</creatorcontrib><creatorcontrib>Sanchez, Herve</creatorcontrib><creatorcontrib>Serrurier, Bernard</creatorcontrib><creatorcontrib>Chapot, Rachel</creatorcontrib><creatorcontrib>Peinnequin, Andre</creatorcontrib><creatorcontrib>Ventura-Clapier, Renee</creatorcontrib><creatorcontrib>Bigard, Xavier</creatorcontrib><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype. muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</description><subject>Age Factors</subject><subject>Animals</subject><subject>Biochemistry, Molecular Biology</subject><subject>Calcineurin</subject><subject>Calcineurin - genetics</subject><subject>Calcineurin - metabolism</subject><subject>Calcineurin Inhibitors</subject><subject>Catalytic Domain</subject><subject>Cyclosporine</subject><subject>Cyclosporine - blood</subject><subject>Cyclosporine - pharmacology</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Enzyme Inhibitors</subject><subject>Enzyme Inhibitors - blood</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene expression</subject><subject>Genotype &amp; phenotype</subject><subject>Growth hormones</subject><subject>Hypothyroidism</subject><subject>Hypothyroidism - metabolism</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Metabolism</subject><subject>Muscle Proteins</subject><subject>Muscle Proteins - genetics</subject><subject>Muscle Proteins - metabolism</subject><subject>Muscle, Skeletal</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - enzymology</subject><subject>Myosin Heavy Chains</subject><subject>Myosin Heavy Chains - metabolism</subject><subject>p38 Mitogen-Activated Protein Kinases</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</subject><subject>Phenotype</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>RNA, Messenger</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA-Binding Proteins</subject><subject>RNA-Binding Proteins - genetics</subject><subject>RNA-Binding Proteins - metabolism</subject><subject>Rodents</subject><subject>Thyroid Hormones</subject><subject>Thyroid Hormones - metabolism</subject><subject>Transcription Factors</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks1u1DAUhS0EokPhBVggiwUrZvBPnJ9lVbUUaSQ2w9pybKfxyLFTO6bkMXhjnE5aEEJiZcn3O9f3-B4A3mK0w5iRT-I4aqf8DiFc0R1BqHoGNrlAtpgx9hxsEG7oFtdFcwZexXhEmWAFeQnOcNVUmGG2AT8P_Ry8UbD3YfBOQxNh0HfJBK1g5wOceg3HXjs_zaOGUxAumsl4F6FxKslMtfMKiTAI6a2_NVLYXO5N-4BC38F8I43TKRiXK1CoZCcYvdUpwiFFafVCBTHF1-BFJ2zUb9bzHHy7vjpc3mz3Xz9_ubzYb2VRk2kryhqRriiLWraiZm2nqrrI5itVL-4kaQshqVSlaFuc3VIpNW0r0VWqlZQ09Bx8PPXtheVjMIMIM_fC8JuLPTcu6jBwhGjNWFN9xxn_cMLH4O-SjhMfTJTaWuG0T5FX-bOLPNl_QYLqkuGGZfD9X-DRp-CyZ04oobig5fIsOUEy-BiD7p5GxYgvKeBrCvhDCviSgix6t3ZO7aDVb8m69gzUq3dz29_nXfOxn6NZdjfz62TtQf-YHjuTpuCYX5UNH1X3x7f9Q_o4y5OE_gKT0dbR</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Koulmann, Nathalie</creator><creator>Bahi, Lahoucine</creator><creator>Ribera, Florence</creator><creator>Sanchez, Herve</creator><creator>Serrurier, Bernard</creator><creator>Chapot, Rachel</creator><creator>Peinnequin, Andre</creator><creator>Ventura-Clapier, Renee</creator><creator>Bigard, Xavier</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7U7</scope><scope>C1K</scope><scope>7TM</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-6116-5795</orcidid><orcidid>https://orcid.org/0000-0002-7488-4123</orcidid></search><sort><creationdate>20080101</creationdate><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><author>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age Factors</topic><topic>Animals</topic><topic>Biochemistry, Molecular Biology</topic><topic>Calcineurin</topic><topic>Calcineurin - genetics</topic><topic>Calcineurin - metabolism</topic><topic>Calcineurin Inhibitors</topic><topic>Catalytic Domain</topic><topic>Cyclosporine</topic><topic>Cyclosporine - blood</topic><topic>Cyclosporine - pharmacology</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Enzyme Inhibitors</topic><topic>Enzyme Inhibitors - blood</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene expression</topic><topic>Genotype &amp; phenotype</topic><topic>Growth hormones</topic><topic>Hypothyroidism</topic><topic>Hypothyroidism - metabolism</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Metabolism</topic><topic>Muscle Proteins</topic><topic>Muscle Proteins - genetics</topic><topic>Muscle Proteins - metabolism</topic><topic>Muscle, Skeletal</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - enzymology</topic><topic>Myosin Heavy Chains</topic><topic>Myosin Heavy Chains - metabolism</topic><topic>p38 Mitogen-Activated Protein Kinases</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</topic><topic>Phenotype</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>RNA, Messenger</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA-Binding Proteins</topic><topic>RNA-Binding Proteins - genetics</topic><topic>RNA-Binding Proteins - metabolism</topic><topic>Rodents</topic><topic>Thyroid Hormones</topic><topic>Thyroid Hormones - metabolism</topic><topic>Transcription Factors</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koulmann, Nathalie</creatorcontrib><creatorcontrib>Bahi, Lahoucine</creatorcontrib><creatorcontrib>Ribera, Florence</creatorcontrib><creatorcontrib>Sanchez, Herve</creatorcontrib><creatorcontrib>Serrurier, Bernard</creatorcontrib><creatorcontrib>Chapot, Rachel</creatorcontrib><creatorcontrib>Peinnequin, Andre</creatorcontrib><creatorcontrib>Ventura-Clapier, Renee</creatorcontrib><creatorcontrib>Bigard, Xavier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koulmann, Nathalie</au><au>Bahi, Lahoucine</au><au>Ribera, Florence</au><au>Sanchez, Herve</au><au>Serrurier, Bernard</au><au>Chapot, Rachel</au><au>Peinnequin, Andre</au><au>Ventura-Clapier, Renee</au><au>Bigard, Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>294</volume><issue>1</issue><spage>E69</spage><epage>E77</epage><pages>E69-E77</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><coden>AJPMD9</coden><abstract>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype. muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>17971515</pmid><doi>10.1152/ajpendo.00173.2007</doi><orcidid>https://orcid.org/0000-0002-6116-5795</orcidid><orcidid>https://orcid.org/0000-0002-7488-4123</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2008-01, Vol.294 (1), p.E69-E77
issn 0193-1849
1522-1555
language eng
recordid cdi_proquest_miscellaneous_20865195
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Age Factors
Animals
Biochemistry, Molecular Biology
Calcineurin
Calcineurin - genetics
Calcineurin - metabolism
Calcineurin Inhibitors
Catalytic Domain
Cyclosporine
Cyclosporine - blood
Cyclosporine - pharmacology
Electrophoresis, Polyacrylamide Gel
Enzyme Inhibitors
Enzyme Inhibitors - blood
Enzyme Inhibitors - pharmacology
Gene expression
Genotype & phenotype
Growth hormones
Hypothyroidism
Hypothyroidism - metabolism
Life Sciences
Male
Metabolism
Muscle Proteins
Muscle Proteins - genetics
Muscle Proteins - metabolism
Muscle, Skeletal
Muscle, Skeletal - drug effects
Muscle, Skeletal - enzymology
Myosin Heavy Chains
Myosin Heavy Chains - metabolism
p38 Mitogen-Activated Protein Kinases
p38 Mitogen-Activated Protein Kinases - metabolism
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
Phenotype
Phosphorylation
Proteins
Rats
Rats, Wistar
RNA, Messenger
RNA, Messenger - metabolism
RNA-Binding Proteins
RNA-Binding Proteins - genetics
RNA-Binding Proteins - metabolism
Rodents
Thyroid Hormones
Thyroid Hormones - metabolism
Transcription Factors
Transcription Factors - genetics
Transcription Factors - metabolism
title Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T00%3A13%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20hormone%20is%20required%20for%20the%20phenotype%20transitions%20induced%20by%20the%20pharmacological%20inhibition%20of%20calcineurin%20in%20adult%20soleus%20muscle%20of%20rats&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Koulmann,%20Nathalie&rft.date=2008-01-01&rft.volume=294&rft.issue=1&rft.spage=E69&rft.epage=E77&rft.pages=E69-E77&rft.issn=0193-1849&rft.eissn=1522-1555&rft.coden=AJPMD9&rft_id=info:doi/10.1152/ajpendo.00173.2007&rft_dat=%3Cproquest_highw%3E70194482%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232314361&rft_id=info:pmid/17971515&rfr_iscdi=true